Logo image of MBI

MBIA INC (MBI) Stock Fundamental Analysis

USA - NYSE:MBI - US55262C1009 - Common Stock

6.83 USD
+0.08 (+1.19%)
Last: 10/31/2025, 8:04:00 PM
6.83 USD
0 (0%)
After Hours: 10/31/2025, 8:04:00 PM
Fundamental Rating

1

Overall MBI gets a fundamental rating of 1 out of 10. We evaluated MBI against 147 industry peers in the Insurance industry. MBI may be in some trouble as it scores bad on both profitability and health. MBI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

MBI had negative earnings in the past year.
MBI had a negative operating cash flow in the past year.
MBI had negative earnings in each of the past 5 years.
MBI had negative operating cash flow in 4 of the past 5 years.
MBI Yearly Net Income VS EBIT VS OCF VS FCFMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -10.54%, MBI is doing worse than 92.52% of the companies in the same industry.
Industry RankSector Rank
ROA -10.54%
ROE N/A
ROIC N/A
ROA(3y)-15.16%
ROA(5y)-13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBI Yearly ROA, ROE, ROICMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBI Yearly Profit, Operating, Gross MarginsMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

0

2. Health

2.1 Basic Checks

The number of shares outstanding for MBI has been increased compared to 1 year ago.
Compared to 5 years ago, MBI has less shares outstanding
The debt/assets ratio for MBI is higher compared to a year ago.
MBI Yearly Shares OutstandingMBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
MBI Yearly Total Debt VS Total AssetsMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
MBI Yearly LT Debt VS Equity VS FCFMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBI Yearly Current Assets VS Current LiabilitesMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.54% over the past year.
The Revenue has grown by 314.58% in the past year. This is a very strong growth!
MBI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -34.49% yearly.
EPS 1Y (TTM)87.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.14%
Revenue 1Y (TTM)314.58%
Revenue growth 3Y-35.84%
Revenue growth 5Y-34.49%
Sales Q2Q%-12.5%

3.2 Future

MBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.76% yearly.
MBI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -13.40% yearly.
EPS Next Y85.89%
EPS Next 2Y36.77%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue Next Year-10.71%
Revenue Next 2Y-13.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MBI Yearly Revenue VS EstimatesMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MBI Yearly EPS VS EstimatesMBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

1

4. Valuation

4.1 Price/Earnings Ratio

MBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MBI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBI Price Earnings VS Forward Price EarningsMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBI Per share dataMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

MBI's earnings are expected to grow with 22.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.77%
EPS Next 3Y22.76%

0

5. Dividend

5.1 Amount

No dividends for MBI!.
Industry RankSector Rank
Dividend Yield N/A

MBIA INC

NYSE:MBI (10/31/2025, 8:04:00 PM)

After market: 6.83 0 (0%)

6.83

+0.08 (+1.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners46.38%
Inst Owner Change0.4%
Ins Owners10.43%
Ins Owner Change0.2%
Market Cap344.85M
Revenue(TTM)103.00M
Net Income(TTM)-225000000
Analysts76.67
Price Target7.65 (12.01%)
Short Float %4.28%
Short Ratio5.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend7.73
Dividend Growth(5Y)97.69%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.31%
Min EPS beat(2)-21.86%
Max EPS beat(2)-14.76%
EPS beat(4)1
Avg EPS beat(4)-6.68%
Min EPS beat(4)-90.1%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-482.92%
EPS beat(12)4
Avg EPS beat(12)-325.68%
EPS beat(16)4
Avg EPS beat(16)-304.83%
Revenue beat(2)1
Avg Revenue beat(2)7.26%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)15.51%
Revenue beat(4)3
Avg Revenue beat(4)26.71%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)65.02%
Revenue beat(8)7
Avg Revenue beat(8)27.17%
Revenue beat(12)11
Avg Revenue beat(12)96.9%
Revenue beat(16)15
Avg Revenue beat(16)136.23%
PT rev (1m)0%
PT rev (3m)15.38%
EPS NQ rev (1m)-57.49%
EPS NQ rev (3m)21.25%
EPS NY rev (1m)0%
EPS NY rev (3m)2.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-3.53
FCFYN/A
OCF(TTM)-3.53
OCFYN/A
SpS2.04
BVpS-42.88
TBVpS-42.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-15.16%
ROA(5y)-13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.14%
EPS Next Y85.89%
EPS Next 2Y36.77%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue 1Y (TTM)314.58%
Revenue growth 3Y-35.84%
Revenue growth 5Y-34.49%
Sales Q2Q%-12.5%
Revenue Next Year-10.71%
Revenue Next 2Y-13.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y97.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.55%
OCF growth 3YN/A
OCF growth 5YN/A

MBIA INC / MBI FAQ

What is the fundamental rating for MBI stock?

ChartMill assigns a fundamental rating of 1 / 10 to MBI.


What is the valuation status of MBIA INC (MBI) stock?

ChartMill assigns a valuation rating of 1 / 10 to MBIA INC (MBI). This can be considered as Overvalued.


How profitable is MBIA INC (MBI) stock?

MBIA INC (MBI) has a profitability rating of 0 / 10.


What is the expected EPS growth for MBIA INC (MBI) stock?

The Earnings per Share (EPS) of MBIA INC (MBI) is expected to grow by 85.89% in the next year.